Weighted Average Number of Shares Outstanding, Diluted of ADMA BIOLOGICS, INC. from Q2 2020 to Q3 2025
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Adma Biologics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q3 2025.
- Adma Biologics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 245M shares, a 0.06% decline year-over-year.
- Adma Biologics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 243M shares, a 8.65% increase from 2023.
- Adma Biologics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 224M shares, a 13.2% increase from 2022.
- Adma Biologics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 198M shares, a 41.8% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)